Consolidated Statements of Earnings - USD ($) shares in Millions, $ in Millions	12 Months Ended
Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2017
Income Statement [Abstract]
Revenue	$ 145,534	$ 136,809	$ 129,976
Cost of products sold	138,700	129,628	123,432
Gross margin	6,834	7,181	6,544
Operating expenses:
Distribution, selling, general and administrative expenses	4,480	4,596	3,775
Restructuring and employee severance	125	176	56
Amortization and other acquisition-related costs	621	707	527
Impairments and (gain)/loss on disposal of assets, net	(488)	1,417	18
Litigation (recoveries)/charges, net	36	159	48
Operating earnings	2,060	126	2,120
Other (income)/expense, net	15	23	(5)
Interest expense, net	294	329	201
Loss on extinguishment of debt	0	2	0
Earnings/(loss) before income taxes	1,751	(228)	1,924
Provision for/(benefit from) income taxes	386	(487)	630
Net earnings	1,365	259	1,294
Less: Net earnings attributable to noncontrolling interests	(2)	(3)	(6)
Net earnings attributable to Cardinal Health, Inc.	$ 1,363	$ 256	$ 1,288
Earnings per common share attributable to Cardinal Health, Inc.
Earnings Per Share, Basic	$ 4.55	$ 0.82	$ 4.06
Earnings Per Share, Diluted	$ 4.53	$ 0.81	$ 4.03
Weighted-average number of common shares outstanding:
Basic (in shares)	300	313	317
Diluted (in shares)	301	315	320

The aggregate expense charged against earnings to allocate the cost of acquired intangible assets and changes in the fair value of contingent consideration obligations. This also represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.

No definition available.